Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

GSK’s Nuvalent buyout delivers again as FDA clears Nelkarmi for lung cancer

GSK has secured a US accelerated approval for its oral lung cancer drug neladalkib, one of two assets at the heart of its $10.6 billion purchase of oncology drugmaker Nuvalent earlier this ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at endpoints.news →

More in Health & Medicine

Fearmongering around fake drugs

As per the last National Drug Survey published in 2017, the volume of counterfeit drugs in the Indian market detected in the survey was at a negligible 0.0245%

More from Tuesday 17 November →